The Review of the Yanghe Decoction About Its Clinical and Experimental Research

Tao Fenfen; Zhao Hourui

doi:doi:

| Peer-Reviewed

The Review of the Yanghe Decoction About Its Clinical and Experimental Research

Tao Fenfen, Zhao Hourui

Published in Asia-Pacific Journal of Chinese Medicine (Volume 1, Issue 1)

Received: 10 April 2019 Accepted: 12 May 2019 Published: 20 May 2019

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

To explore the clinical effect and treatment mechanism of Yanghe decoction, to develop its utilization in clinic and the curative effect of TCM, we made a comprehensive summary of the status quo of clinical and experimental research of Yanghe decoction. By reading literature of nearly 10 years, it is evidential that Yanghe decoction has the effect of anti-inflammatory, anti-cancer and analgesic efficacy, widely used in clinical inside and outside, department of gynecology and pediatrics, especially in tumor, orthopedics, gynecology, peripheral vascular disease whose clinical reports is more. We found those diseases have Yang deficiency, qi and blood impassability in common, which reflects the characteristics of traditional Chinese medicine. Some progress has been made in the basic study of Yanghe decoction treating mastitis, breast cancer, ankylosing spondylitis, which also provides a basis for exploring its treatment mechanism.

Published in	Asia-Pacific Journal of Chinese Medicine (Volume 1, Issue 1)
Page(s)	13-18
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Yanghe Decoction, Clinical Application, The Experimental Research, Review

References

[1]	Libing Z, Lingru L, Yingshuai L, et al. Chinese Herbal Medicine as an Adjunctive Therapy for Breast Cancer: A Systematic Review and Meta-Analysis [J]. Evidence-Based Complementary and Alternative Medicine, 2016, 2016:1-17.
[2]	Jianwei D, Yun H, Yiqi Y, et al. The Exposition of the Theory on Yanghe Decoction Treating Breast Cancer[J]. World Chinese Medicine, 2015.
[3]	彭仁通.温阳法联合TP方案治疗晚期非小细胞肺癌临床研究[J].中医学报,2016,31(02):175-178。
[4]	王明军.阳和汤联合化疗治疗晚期乳腺癌30例临床观察[J].中国民族民间医药,2017,26(09):110-111。
[5]	邵轶群,杨明,贾默然等.阳和汤对晚期前列腺癌患者疼痛及生活质量的改善作用[J].陕西中医,2016,37(03):319-321。
[6]	贺云周,杜瑜,齐彦.阳和汤治疗阳虚型支气管哮喘50例临床疗效观察[J].内蒙古中医药,2018,37(07):13-14。
[7]	李小军.王玉光应用名方治疗慢性咳嗽举隅[J].中国民间疗法,2019,27(03):11-12。
[8]	申志勇.阳和汤治疗肾阳虚哮喘96例疗效观察[J].国医论坛,2017,32(01):40-41。
[9]	郭雨浩,柏树纲.中西医结合治疗脾肾阳虚型溃疡性结肠炎疗效观察[J].山西中医,2015,31(08):21-22。
[10]	王彦斐,朱曙东.阳和汤治疗脾肾阳虚型克罗恩病临床疗效观察[J].山东中医药大学学报,2017,41(02):138-140。
[11]	张毅鹏.加味阳和汤防治奥沙利铂周围神经毒性的临床观察[J].中国现代医生,2018,56(15):124-126。
[12]	孙文磊. 阳和汤加减联合激光治疗带状疱疹后神经痛的临床观察[D].黑龙江中医药大学,2016。
[13]	田曼,祁正亮,陈延.阳和汤联合血栓通治疗阳虚寒凝证糖尿病周围神经病变的临床研究[J].现代中西医结合杂志,2019,28(05):465-468。
[14]	菅振刚.麻黄附子细辛汤合阳和汤加减在缓慢性心律失常治疗中的应用价值[J].中西医结合心血管病电子杂志,2018,6(34):163-164。
[15]	曲争艳,张利敏,率中泰.加味阳和汤治疗心力衰竭20例[J].光明中医,2016,31(19):2822-2825。
[16]	崔永明.阳和汤配合蒸熨法治疗未溃期脱疽的临床效果[J].中国药物经济学,2017,12(05):65-67。
[17]	石光煜,黄艳洪,张百亮等.阳和汤加味治疗下肢动脉硬化闭塞症35例临床观察[J].中国中医药科技,2016,23(01):75-76。
[18]	李政.阳和汤联合纤维乳管镜治疗浆细胞性乳腺炎疗效观察[J].中医学报,2018,33(06):1128-1131。
[19]	陆清,张馨月,梁宏莉等.温阳通络方治疗浆细胞性乳腺炎183例[J].光明中医,2016,31(22):3275-3277。
[20]	陈星,高文飞.阳和汤联合玻璃酸钠关节腔内注射治疗膝关节骨性关节炎临床研究[J].新中医,2018,50(06):112-114。
[21]	张玲玲,王志杰,刘子琦.阳和汤联合柳氮磺吡啶治疗强直性脊柱炎临床观察[J].中国民族民间医药,2018,27(20):96-98。
[22]	Wang Y, Xiao X. Clinical Efficacy of Modified Yanghe Decoction in Ankylosing Spondylitis: A Randomized Controlled Trial. [J]. Medical Science Monitor International Medical Journal of Experimental & Clinical Research, 2018, 24:2912-2918.
[23]	周伟.阳和汤联合西药抗结核药物治疗骨结核的临床效果观察[J].临床医药文献电子杂志,2018,5(40):165。
[24]	陶茂灿,贺倩倩,孙丹等.阳和汤加减方治疗脾肾阳虚型系统性硬皮病临床疗效观察及机制探讨[J].浙江中医药大学学报,2016,40(06):445-450。
[25]	陈力槟,林笑娟,黄鸿健.阳和汤加减治疗慢性荨麻疹42例[J].福建中医药,2018,49(06):20-22。
[26]	彭丽娟,朱金土.从温阳散寒法论治皮下脂肪瘤[J].新中医,2019,51(01):236-237。
[27]	陈海庚.阳和汤治疗虚寒型痛经的临床疗效分析[J].中国医药指南,2016,14(35):205-206。
[28]	王建中.多囊卵巢综合征致不孕症验案举隅[J].山西中医,2018,34(12):33+39。
[29]	陈波,和杏花,李芳.阳和汤加减治疗流行性腮腺炎30例疗效观察[J].中医临床研究,2016,8(18):97+101.
[30]	Wu F, Li H, Jin L, et al. Deer antler base as a traditional Chinese medicine: A review of its traditional uses, chemistry and pharmacology [J]. Journal of Ethnopharmacology, 2013, 145(2):403-415.
[31]	Park K S. Catalpol reduces the production of inflammatory mediators via PPAR-γ activation in human intestinal Caco-2 cells [J]. Journal of Natural Medicines, 2016, 70(3):620-626.
[32]	Wang Q, Shu Z, Xing N, et al. A pure polysaccharide from Ephedra sinica treating on arthritis and inhibiting cytokines expression [J]. International Journal of Biological Macromolecules, 2016, 86:177-188.
[33]	Yang H, Cheng X, Yang Y L, et al. Ramulus Cinnamomi extract attenuates neuroinflammatory responses via downregulating TLR4/MyD88 signaling pathway in BV2 cells [J]. Neural Regeneration Research, 2017, 12(11):1860-1864.
[34]	Zheng F, Wei P, Huo H, et al. Neuroprotective Effect of Gui Zhi (Ramulus Cinnamomi) on Ma Huang- (Herb Ephedra-) Induced Toxicity in Rats Treated with a Ma Huang-Gui Zhi Herb Pair [J]. Evidence-Based Complementray and Alternative Medicine, 2015, (2015-1-26), 2015, 2015(3):913461.
[35]	黄芊,张扶莉,李雪莲等.阳和汤对人乳腺癌MCF-7细胞及其PI3K/Akt信号通路的影响[J].四川中医,2019(02):47-50。
[36]	Zeng L, Yang K. Exploring the pharmacological mechanism of Yanghe Decoction on HER2-positive breast cancer by a network pharmacology approach [J]. Journal of Ethnopharmacology, 2017, 199:68-85.
[37]	王俊.阳和汤对急性乳腺炎大鼠蛋白质组的影响[J].世界最新医学信息文摘,2019,19(06):188-190+192。
[38]	Burek C L, Talor M V. Environmental triggers of autoimmune thyroiditis [J]. Journal of Autoimmunity, 2009, 33(3-4):0-189.
[39]	董笑克,邓莉,白颖等.阳和汤对自身免疫性甲状腺炎大鼠甲状腺结构及甲状腺自身抗体的影响[J].环球中医药,2017,10(06):655-658。
[40]	Gopalakrishnan S, Sen S, Adhikari J S, et al. The role of T-lymphocyte subsets and interleukin-5 blood levels among Indian subjects with autoimmune thyroid disease[J]. Hormones, 2010, 9(1):76-81.
[41]	许波. 阳和汤对兔膝骨关节炎模型IL-1、TNF-α含量影响的实验研究[D].福建中医药大学,2016。
[42]	陈星,高文飞.阳和汤联合玻璃酸钠关节腔内注射治疗膝关节骨性关节炎临床研究[J].新中医,2018,50(06):112-114。
[43]	陈朝蔚,陈永强.阳和汤治疗兔膝骨性关节炎的作用机制[J].中医正骨,2008(04):11-12+80。
[44]	谢求恩,张雄,徐永贵.阳和汤对膝关节骨性关节炎患者血清及滑液中HIF-1α和VEGF表达的影响研究[J].环球中医药,2018,11(03):458-461。
[45]	Kuijper A, Groep P V D, Wall E V D, et al. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast [J]. Breast cancer research: BCR, 2005, 7(5):R808-18.
[46]	Walsh D A. Angiogenesis and arthritis. [J]. Rheumatology, 1999, 38(2):103-12.
[47]	Ruegg C, Mariotti A. Vascular integrins: pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis. [J] Cell Mollife Sci, 2003, 60(6):1135-1157.
[48]	Maes C, Carmeliet P, Moermans K, et al. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. [J]. Mechanisms of Development, 2002, 111(1):61-73.
[49]	张玲玲,王志杰,刘子琦.阳和汤联合柳氮磺吡啶治疗强直性脊柱炎临床观察[J].中国民族民间医药,2018,27(20):96-98。
[50]	黄立中,徐琳本,张晓明等.阳和汤镇痛及抗炎作用的实验研究[J].湖南中医杂志,2002(05):49-50。

Cite This Article

Plain Text BibTeX RIS

APA Style

Tao Fenfen, Zhao Hourui. (2019). The Review of the Yanghe Decoction About Its Clinical and Experimental Research. Asia-Pacific Journal of Chinese Medicine, 1(1), 13-18.

Copy | Download

ACS Style

Tao Fenfen; Zhao Hourui. The Review of the Yanghe Decoction About Its Clinical and Experimental Research. Asia-Pac. J. Chin. Med. 2019, 1(1), 13-18.

Copy | Download

AMA Style

Tao Fenfen, Zhao Hourui. The Review of the Yanghe Decoction About Its Clinical and Experimental Research. Asia-Pac J Chin Med. 2019;1(1):13-18.

Copy | Download

@article{10038918,
  author = {Tao Fenfen and Zhao Hourui},
  title = {The Review of the Yanghe Decoction About Its Clinical and Experimental Research},
  journal = {Asia-Pacific Journal of Chinese Medicine},
  volume = {1},
  number = {1},
  pages = {13-18},
  url = {https://www.sciencepublishinggroup.com/article/10038918},
  abstract = {To explore the clinical effect and treatment mechanism of Yanghe decoction, to develop its utilization in clinic and the curative effect of TCM, we made a comprehensive summary of the status quo of clinical and experimental research of Yanghe decoction. By reading literature of nearly 10 years, it is evidential that Yanghe decoction has the effect of anti-inflammatory, anti-cancer and analgesic efficacy, widely used in clinical inside and outside, department of gynecology and pediatrics, especially in tumor, orthopedics, gynecology, peripheral vascular disease whose clinical reports is more. We found those diseases have Yang deficiency, qi and blood impassability in common, which reflects the characteristics of traditional Chinese medicine. Some progress has been made in the basic study of Yanghe decoction treating mastitis, breast cancer, ankylosing spondylitis, which also provides a basis for exploring its treatment mechanism.},
 year = {2019}
}

Copy | Download

TY  - JOUR
T1  - The Review of the Yanghe Decoction About Its Clinical and Experimental Research
AU  - Tao Fenfen
AU  - Zhao Hourui
Y1  - 2019/05/20
PY  - 2019
T2  - Asia-Pacific Journal of Chinese Medicine
JF  - Asia-Pacific Journal of Chinese Medicine
JO  - Asia-Pacific Journal of Chinese Medicine
SP  - 13
EP  - 18
PB  - Science Publishing Group
UR  - http://www.sciencepg.com/article/10038918
AB  - To explore the clinical effect and treatment mechanism of Yanghe decoction, to develop its utilization in clinic and the curative effect of TCM, we made a comprehensive summary of the status quo of clinical and experimental research of Yanghe decoction. By reading literature of nearly 10 years, it is evidential that Yanghe decoction has the effect of anti-inflammatory, anti-cancer and analgesic efficacy, widely used in clinical inside and outside, department of gynecology and pediatrics, especially in tumor, orthopedics, gynecology, peripheral vascular disease whose clinical reports is more. We found those diseases have Yang deficiency, qi and blood impassability in common, which reflects the characteristics of traditional Chinese medicine. Some progress has been made in the basic study of Yanghe decoction treating mastitis, breast cancer, ankylosing spondylitis, which also provides a basis for exploring its treatment mechanism.
VL  - 1
IS  - 1
ER  -

Copy | Download

Author Information

Tao Fenfen

Department of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, China
Zhao Hourui

Department of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, China

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Tao Fenfen, Zhao Hourui. (2019). The Review of the Yanghe Decoction About Its Clinical and Experimental Research. Asia-Pacific Journal of Chinese Medicine, 1(1), 13-18.

Copy | Download

ACS Style

Tao Fenfen; Zhao Hourui. The Review of the Yanghe Decoction About Its Clinical and Experimental Research. Asia-Pac. J. Chin. Med. 2019, 1(1), 13-18.

Copy | Download

AMA Style

Tao Fenfen, Zhao Hourui. The Review of the Yanghe Decoction About Its Clinical and Experimental Research. Asia-Pac J Chin Med. 2019;1(1):13-18.

Copy | Download

@article{10038918,
  author = {Tao Fenfen and Zhao Hourui},
  title = {The Review of the Yanghe Decoction About Its Clinical and Experimental Research},
  journal = {Asia-Pacific Journal of Chinese Medicine},
  volume = {1},
  number = {1},
  pages = {13-18},
  url = {https://www.sciencepublishinggroup.com/article/10038918},
  abstract = {To explore the clinical effect and treatment mechanism of Yanghe decoction, to develop its utilization in clinic and the curative effect of TCM, we made a comprehensive summary of the status quo of clinical and experimental research of Yanghe decoction. By reading literature of nearly 10 years, it is evidential that Yanghe decoction has the effect of anti-inflammatory, anti-cancer and analgesic efficacy, widely used in clinical inside and outside, department of gynecology and pediatrics, especially in tumor, orthopedics, gynecology, peripheral vascular disease whose clinical reports is more. We found those diseases have Yang deficiency, qi and blood impassability in common, which reflects the characteristics of traditional Chinese medicine. Some progress has been made in the basic study of Yanghe decoction treating mastitis, breast cancer, ankylosing spondylitis, which also provides a basis for exploring its treatment mechanism.},
 year = {2019}
}

Copy | Download

TY  - JOUR
T1  - The Review of the Yanghe Decoction About Its Clinical and Experimental Research
AU  - Tao Fenfen
AU  - Zhao Hourui
Y1  - 2019/05/20
PY  - 2019
T2  - Asia-Pacific Journal of Chinese Medicine
JF  - Asia-Pacific Journal of Chinese Medicine
JO  - Asia-Pacific Journal of Chinese Medicine
SP  - 13
EP  - 18
PB  - Science Publishing Group
UR  - http://www.sciencepg.com/article/10038918
AB  - To explore the clinical effect and treatment mechanism of Yanghe decoction, to develop its utilization in clinic and the curative effect of TCM, we made a comprehensive summary of the status quo of clinical and experimental research of Yanghe decoction. By reading literature of nearly 10 years, it is evidential that Yanghe decoction has the effect of anti-inflammatory, anti-cancer and analgesic efficacy, widely used in clinical inside and outside, department of gynecology and pediatrics, especially in tumor, orthopedics, gynecology, peripheral vascular disease whose clinical reports is more. We found those diseases have Yang deficiency, qi and blood impassability in common, which reflects the characteristics of traditional Chinese medicine. Some progress has been made in the basic study of Yanghe decoction treating mastitis, breast cancer, ankylosing spondylitis, which also provides a basis for exploring its treatment mechanism.
VL  - 1
IS  - 1
ER  -

Copy | Download